The mechanisms by which polyamines accelerate tumor spread

<p>Abstract</p> <p>Increased polyamine concentrations in the blood and urine of cancer patients reflect the enhanced levels of polyamine synthesis in cancer tissues arising from increased activity of enzymes responsible for polyamine synthesis. In addition to their <it>de nov...

Full description

Bibliographic Details
Main Author: Soda Kuniyasu
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://www.jeccr.com/content/30/1/95
_version_ 1818567466857529344
author Soda Kuniyasu
author_facet Soda Kuniyasu
author_sort Soda Kuniyasu
collection DOAJ
description <p>Abstract</p> <p>Increased polyamine concentrations in the blood and urine of cancer patients reflect the enhanced levels of polyamine synthesis in cancer tissues arising from increased activity of enzymes responsible for polyamine synthesis. In addition to their <it>de novo </it>polyamine synthesis, cells can take up polyamines from extracellular sources, such as cancer tissues, food, and intestinal microbiota. Because polyamines are indispensable for cell growth, increased polyamine availability enhances cell growth. However, the malignant potential of cancer is determined by its capability to invade to surrounding tissues and metastasize to distant organs. The mechanisms by which increased polyamine levels enhance the malignant potential of cancer cells and decrease anti-tumor immunity are reviewed. Cancer cells with a greater capability to synthesize polyamines are associated with increased production of proteinases, such as serine proteinase, matrix metalloproteinases, cathepsins, and plasminogen activator, which can degrade surrounding tissues. Although cancer tissues produce vascular growth factors, their deregulated growth induces hypoxia, which in turn enhances polyamine uptake by cancer cells to further augment cell migration and suppress CD44 expression. Increased polyamine uptake by immune cells also results in reduced cytokine production needed for anti-tumor activities and decreases expression of adhesion molecules involved in anti-tumor immunity, such as CD11a and CD56. Immune cells in an environment with increased polyamine levels lose anti-tumor immune functions, such as lymphokine activated killer activities. Recent investigations revealed that increased polyamine availability enhances the capability of cancer cells to invade and metastasize to new tissues while diminishing immune cells' anti-tumor immune functions.</p>
first_indexed 2024-12-14T06:23:47Z
format Article
id doaj.art-cb4a683a858942ccb741e79e413fcae8
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-14T06:23:47Z
publishDate 2011-10-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-cb4a683a858942ccb741e79e413fcae82022-12-21T23:13:45ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662011-10-013019510.1186/1756-9966-30-95The mechanisms by which polyamines accelerate tumor spreadSoda Kuniyasu<p>Abstract</p> <p>Increased polyamine concentrations in the blood and urine of cancer patients reflect the enhanced levels of polyamine synthesis in cancer tissues arising from increased activity of enzymes responsible for polyamine synthesis. In addition to their <it>de novo </it>polyamine synthesis, cells can take up polyamines from extracellular sources, such as cancer tissues, food, and intestinal microbiota. Because polyamines are indispensable for cell growth, increased polyamine availability enhances cell growth. However, the malignant potential of cancer is determined by its capability to invade to surrounding tissues and metastasize to distant organs. The mechanisms by which increased polyamine levels enhance the malignant potential of cancer cells and decrease anti-tumor immunity are reviewed. Cancer cells with a greater capability to synthesize polyamines are associated with increased production of proteinases, such as serine proteinase, matrix metalloproteinases, cathepsins, and plasminogen activator, which can degrade surrounding tissues. Although cancer tissues produce vascular growth factors, their deregulated growth induces hypoxia, which in turn enhances polyamine uptake by cancer cells to further augment cell migration and suppress CD44 expression. Increased polyamine uptake by immune cells also results in reduced cytokine production needed for anti-tumor activities and decreases expression of adhesion molecules involved in anti-tumor immunity, such as CD11a and CD56. Immune cells in an environment with increased polyamine levels lose anti-tumor immune functions, such as lymphokine activated killer activities. Recent investigations revealed that increased polyamine availability enhances the capability of cancer cells to invade and metastasize to new tissues while diminishing immune cells' anti-tumor immune functions.</p>http://www.jeccr.com/content/30/1/95PolyaminemetastasissperminespermidineLAKLFA-1
spellingShingle Soda Kuniyasu
The mechanisms by which polyamines accelerate tumor spread
Journal of Experimental & Clinical Cancer Research
Polyamine
metastasis
spermine
spermidine
LAK
LFA-1
title The mechanisms by which polyamines accelerate tumor spread
title_full The mechanisms by which polyamines accelerate tumor spread
title_fullStr The mechanisms by which polyamines accelerate tumor spread
title_full_unstemmed The mechanisms by which polyamines accelerate tumor spread
title_short The mechanisms by which polyamines accelerate tumor spread
title_sort mechanisms by which polyamines accelerate tumor spread
topic Polyamine
metastasis
spermine
spermidine
LAK
LFA-1
url http://www.jeccr.com/content/30/1/95
work_keys_str_mv AT sodakuniyasu themechanismsbywhichpolyaminesacceleratetumorspread
AT sodakuniyasu mechanismsbywhichpolyaminesacceleratetumorspread